545393-60-0 Usage
Chemical Family
2-(2-(3-aminophenoxy)ethyl)isoindoline-1,3-dione belongs to the isoindoline-1,3-dione family.
Core Structure
The compound has an isoindoline-1,3-dione core.
Substituents
The core structure has a phenyl group and an aminoalkyl group attached.
Versatile Reactivity
The compound is often used as a building block for the synthesis of various pharmaceuticals and agrochemicals due to its versatile reactivity.
Therapeutic Properties
2-(2-(3-aminophenoxy)ethyl)isoindoline-1,3-dione has potential therapeutic properties and has been studied for its potential as an antioxidant, anti-inflammatory, and antitumor agent.
Medicinal Chemistry
The compound is of interest in the field of medicinal chemistry due to its potential therapeutic properties.
Fluorescent Label
It can be used as a fluorescent label for bioanalytical applications.
Biological Research
2-(2-(3-aminophenoxy)ethyl)isoindoline-1,3-dione is a valuable tool in biological research due to its use as a fluorescent label.
Check Digit Verification of cas no
The CAS Registry Mumber 545393-60-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,4,5,3,9 and 3 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 545393-60:
(8*5)+(7*4)+(6*5)+(5*3)+(4*9)+(3*3)+(2*6)+(1*0)=170
170 % 10 = 0
So 545393-60-0 is a valid CAS Registry Number.
545393-60-0Relevant academic research and scientific papers
Vanilloid receptor ligands and their use in treatments
-
, (2008/06/13)
Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritis, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
